Edition:
United Kingdom

Onconova Therapeutics Inc (ONTX.OQ)

ONTX.OQ on NASDAQ Stock Exchange Capital Market

0.41USD
17 Aug 2018
Change (% chg)

$0.00 (+0.00%)
Prev Close
$0.41
Open
$0.42
Day's High
$0.42
Day's Low
$0.41
Volume
7,928
Avg. Vol
304,030
52-wk High
$2.83
52-wk Low
$0.33

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Mar '18 0.56 -0.336
FY 2017 Dec '17 0.14 -0.611
Sep '17 0.11 -0.707
Jun '17 0.32 -0.287
Mar '17 0.21 -1.232
FY 2016 Dec '16 0.17 -0.804
Sep '16 1.65 -0.294
Jun '16 2.25 -1.964
Mar '16 1.47 -2.650
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Sep-18 3 0.67 1.87 0.00 --
Quarter Ending Dec-18 3 0.74 2.08 0.00 --
Year Ending Dec-18 3 2.46 5.00 1.05 3.71
Year Ending Dec-19 3 3.22 8.50 0.00 22.97
Earnings (per share)
Quarter Ending Sep-18 3 -0.08 -0.05 -0.09 --
Quarter Ending Dec-18 3 -0.08 -0.06 -0.09 --
Year Ending Dec-18 3 -0.44 -0.31 -0.59 -2.12
Year Ending Dec-19 3 -0.35 -0.28 -0.39 -1.52
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 30.93 32.76
P/E High - Last 5 Yrs. -- 40.66 45.44
P/E Low - Last 5 Yrs. -- 23.69 24.26
Beta 0.14 0.90 0.89
Price to Sales (TTM) 7.31 3.94 5.75
Price to Book (MRQ) -- 4.88 5.47
Price to Tangible Book (MRQ) -- 5.70 7.04
Price to Cash Flow (TTM) -- 22.85 23.29
% Owned Institutions 26.87 1.23 2.21

Dividends

  Company industry sector
Dividend Yield -- 1.57 1.51
Dividend Yield - 5 Year Avg -- 1.58 1.52
Dividend 5 Year Growth Rate -- 4.35 5.22
Payout Ratio(TTM) -- 45.85 43.78

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -85.59 2.27 8.01
Sales (TTM) vs TTM 1 Yr. Ago -84.22 4.77 5.64
Sales - 5 Yr. Growth Rate 30.12 9.94 10.18
EPS (MRQ) vs Qtr. 1 Yr. Ago 85.38 17.61 20.60
EPS (TTM) vs TTM 1 Yr. Ago 21.60 -- --
EPS - 5 Yr. Growth Rate -- 9.75 10.66
Capital Spending - 5 Yr. Growth Rate -- 15.37 15.34

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 2.15 2.22
Current Ratio (MRQ) 1.62 2.94 3.03
LT Debt to Equity (MRQ) -- 10.03 12.51
Total Debt to Equity (MRQ) -- 14.07 16.85
Interest Coverage (TTM) -- 35.77 32.63

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 54.71 54.37
Gross Margin - 5 Yr. Avg. -- 52.10 52.17
EBITD Margin (TTM) -998.77 -- --
EBITD - 5 Yr. Avg -282.89 18.48 10.65
Operating Margin (TTM) -1,002.80 14.31 4.32
Operating Margin - 5 Yr. Avg. -285.00 14.43 6.06
Pre-Tax Margin (TTM) -761.54 14.80 5.18
Pre-Tax Margin - 5 Yr. Avg. -290.16 14.82 6.49
Net Profit Margin (TTM) -762.13 11.05 1.48
Net Profit Margin - 5 Yr. Avg. -290.86 11.12 2.77
Effective Tax Rate (TTM) -- 23.22 23.11
Effective Tax Rate - 5 Yr. Avg. -- 23.48 23.97

Efficiency

  Company industry sector
Revenue/Employee (TTM) 102,522 952,976,482 860,364,355
Net Income/Employee (TTM) -781,348 112,117,219 101,205,920
Receivable Turnover (TTM) 1.98 5.72 5.87
Inventory Turnover (TTM) -- 2.63 3.41
Asset Turnover (TTM) 0.15 0.96 0.94

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -111.27 11.58 11.13
Return on Assets - 5 Yr. Avg. -73.07 12.95 12.40
Return on Investment (TTM) -307.64 15.07 14.61
Return on Investment - 5 Yr. Avg. -96.91 16.90 16.13
Return on Equity (TTM) -4,335.58 16.59 16.33
Return on Equity - 5 Yr. Avg. -- 17.97 17.39
  1 Year 3 Year 5 Year
Sales % -51.59 5.28 30.12
EPS (TTM) % 57.87 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Onconova Therapeutics Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 52.73%
# of Holders: 34
Total Shares Held: 44,879,430
3 Mo. Net Change: 37,581,688
# New Positions: 11
# Closed Positions: 4
# Increased Positions: 20
# Reduced Positions: 6
# Net Buyers: 14
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.